Efficacy and Safety of Canakinumab in Patients with Active Systemic Juvenile Idiopathic Arthritis and Fever: Results From Two Pivotal Phase 3 Trials.

被引：0
|
作者：
Brunner, Hermine I. [1 ]
Ruperto, Nicolino [2 ]
Quartier, Pierre [3 ]
Constantin, Tamas [2 ]
Wulffraat, Nico [2 ]
Horneff, Gerd [2 ]
Brik, Riva [2 ]
McCann, Liza [2 ]
Ozdogan, Huri [2 ]
Rutkowska-Sak, Lidia [2 ]
Schneider, Rayfel [1 ]
Berkun, Yackov [2 ]
Calvo, Inmaculada [2 ]
Erguven, Muferet [2 ]
Goffin, Laurence [2 ]
Hofer, Michael [2 ]
Kallinich, Tilmann [2 ]
Lheritier, Karine [4 ]
Abrams, Ken [5 ]
Stancati, Andrea [4 ]
Lovell, D. J. [6 ]
Martini, Alberto [2 ]
机构：
[1] Pediat Rheumatol Collaborat Study Grp PRCSG, Cincinnati, OH USA
[2] Paediat Rheumatol Int Trials Org PRINTO, Ist Giannina Gaslini, Genoa, Italy
[3] Necker Enfants Malades Hosp, Paris, France
[4] Novartis Pharma AG, Basel, Switzerland
[5] Novartis Pharmaceut, E Hanover, NJ USA
[6] Cincinnati Childrens Hosp, Cincinnati, OH USA
来源：
ARTHRITIS AND RHEUMATISM | 2012年 / 64卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
759
引用
收藏
页码：S326 / S327
页数：2
相关论文
共 50 条
  • [1] Efficacy and Safety of Canakinumab in Children with Systemic Juvenile Idiopathic Arthritis: Results from the Phase 3 Extension Study
    Brunner, Hermine I.
    Ruperto, Nicolino
    Quartier, Pierre
    Constantin, Tamas
    Alexeeva, Ekaterina
    Kone-Paut, Isabelle
    Marzan, Katherine
    Wulffraat, Nico
    Schneider, Rayfel
    Padeh, Shai
    Chasnyk, Vyacheslav
    Wouters, Carine
    Kuemmerle-Deschner, Jasmin B.
    Kallinich, Tilmann
    Lauwerys, Bernard
    Haddad, Elie
    Nasonov, Evgeny
    Trachana, Maria
    Vougiouka, Olga
    Leon, Karolynn
    Speziale, Antonio
    Lheritier, Karine
    Martini, Alberto
    Lovell, Daniel
    [J]. ARTHRITIS & RHEUMATOLOGY, 2015, 67
  • [2] EFFICACY AND SAFETY OF CANAKINUMAB IN CHILDREN WITH SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS WITH AND WITHOUT FEVER
    Ruperto, N.
    Brunner, H.
    Quartier, P.
    Constantin, T.
    Alexeeva, E.
    Kone-Paut, I.
    Marzan, K.
    Wulffraat, N.
    Schneider, R.
    Padeh, S.
    Chasnyk, V.
    Wouters, C.
    Deschner, J. Kummerle
    Kallinich, T.
    Lauwerys, B.
    Haddad, E.
    Nasonov, E.
    Trachana, M.
    Vougiouka, O.
    Abrams, K.
    Leon, K.
    Lheritier, K.
    Martini, A.
    Lovell, D.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 608 - 608
  • [3] Long-term Efficacy and Safety of Canakinumab in Patients With Active Systemic Juvenile Idiopathic Arthritis (SJIA): Results From a Phase III
    Brunner, Hermine
    Ruperto, Nicolino
    Quartier, Pierre
    Constantin, Tamas
    Alexeeva, Ekaterina
    Kone-Paut, Isabelle
    Marzan, Katherine
    Wulffraat, Nico
    Schneider, Rayfel
    Padeh, Shai
    Chasnyk, Vyacheslav
    Wouters, Carine
    Kuemmerle-Deschner, Jasmin B.
    Kallinich, Tilmann
    Lauwerys, Bernard
    Haddad, Elie
    Nasonov, Evgeny L.
    Trachana, Maria
    Vougiouka, Olga
    Leon, Karolynn
    Vritzali, Eleni
    Lheritier, Karine
    Martini, Alberto
    Lovell, Daniel
    [J]. ARTHRITIS & RHEUMATOLOGY, 2017, 69 : 64 - 66
  • [4] Canakinumab in patients with systemic juvenile idiopathic arthritis and active systemic features: results from the 5-year long-term extension of the phase III pivotal trials
    Ruperto, Nicolino
    Brunner, Hermine I.
    Quartier, Pierre
    Constantin, Tamas
    Wulffraat, Nico M.
    Horneff, Gerd
    Kasapcopur, Ozgur
    Schneider, Rayfel
    Anton, Jordi
    Barash, Judith
    Berner, Reinhard
    Corona, Fabrizia
    Cuttica, Ruben
    Fouillet-desjonqueres, Marine
    Fischbach, Michel
    Foster, Helen E.
    Foell, Dirk
    Radominski, Sebastiao C.
    Ramanan, Athimalaipet V.
    Trauzeddel, Ralf
    Unsal, Erbil
    Levy, Jeremy
    Vritzali, Eleni
    Martini, Alberto
    Lovell, Daniel J.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 (12) : 1710 - 1719
  • [5] Two Randomized Trials of Canakinumab in Systemic Juvenile Idiopathic Arthritis
    Ruperto, Nicolino
    Brunner, Hermine I.
    Quartier, Pierre
    Constantin, Tamas
    Wulffraat, Nico
    Horneff, Gerd
    Brik, Riva
    McCann, Liza
    Kasapcopur, Ozgur
    Rutkowska-Sak, Lidia
    Schneider, Rayfel
    Berkun, Yackov
    Calvo, Inmaculada
    Erguven, Muferet
    Goffin, Laurence
    Hofer, Michael
    Kallinich, Tilmann
    Oliveira, Sheila K.
    Uziel, Yosef
    Viola, Stefania
    Nistala, Kiran
    Wouters, Carine
    Cimaz, Rolando
    Ferrandiz, Manuel A.
    Flato, Berit
    Gamir, Maria Luz
    Kone-Paut, Isabelle
    Grom, Alexei
    Magnusson, Bo
    Ozen, Seza
    Sztajnbok, Flavio
    Lheritier, Karine
    Abrams, Ken
    Kim, Dennis
    Martini, Alberto
    Lovell, Daniel J.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2012, 367 (25): : 2396 - 2406
  • [6] Long-Term Efficacy and Safety of Canakinumab in Patients with Active Systemic Juvenile Idiopathic Arthritis (SJIA): Results from a PHASE III Extension Study
    Brunner, Hermine I.
    Ruperto, Nicolino
    Quartier, Pierre
    Constantin', Tamas
    Alexeeva, Ekaterina
    Kone-Paut, Isabelle
    Marzan, Katherine
    Wulffraat, Nico
    Schneider, Rayfel
    Padeh, Shai
    Chasnyk, Vyacheslav
    Wouters, Carine
    Kuemmerle-Deschner, Jasmin B.
    Kallinich, Tilmann
    Lauwerys, Bernard
    Haddad, Elie
    Nasonov, Evgeny L.
    Trachana, Maria
    Vougiouka, Olga
    Leon, Karolynn
    Vritzali, Eleni
    Lheritier, Karine
    Martinis, Alberto
    Lovell, Daniel J.
    [J]. ARTHRITIS & RHEUMATOLOGY, 2016, 68
  • [7] Long term efficacy and safety of canakinumab in children with systemic juvenile idiopathic arthritis with and without fever
    Horneff G.
    Ruperto N.
    Brunner H.
    Quartier P.
    Constantin T.
    Alexeeva E.
    Kone-Paut I.
    Marzan K.
    Wulffraat N.
    Schneider R.
    Padeh S.
    Chasnyk V.
    Wouters C.
    Deschner J.K.
    Kallinich T.
    Lauwerys B.
    Haddad E.
    Nasonov E.
    Trachana M.
    Vougiouka O.
    Abrams K.
    Leon K.
    Lheritier K.
    Martini A.
    Lovell D.
    [J]. Pediatric Rheumatology, 13 (Suppl 1)
  • [8] Efficacy and Safety of Canakinumab in Patients With Systemic Juvenile Idiopathic Arthritis With and Without Fever at Baseline: Results From an Open-Label, Active-Treatment Extension Study
    Brunner, Hermine, I
    Quartier, Pierre
    Alexeeva, Ekaterina
    Constantin, Tamas
    Kone-Paut, Isabelle
    Marzan, Katherine
    Schneider, Rayfel
    Wulffraat, Nico M.
    Chasnyk, Vyacheslav
    Tirosh, Irit
    Kallinich, Tilmann
    Kuemmerle-Deschner, Jasmin
    Wouters, Carine
    Lauwerys, Bernard
    Nikishina, Irina
    Trachana, Maria
    Vougiouka, Olga
    Martini, Alberto
    Lovell, Daniel J.
    Levy, Jeremy
    Vritzali, Eleni
    Ruperto, Nicolino
    [J]. ARTHRITIS & RHEUMATOLOGY, 2020, 72 (12) : 2147 - 2158
  • [9] TREATING TO TARGET WITH CANAKINUMAB IN PATIENTS WITH ACTIVE SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS: RESULTS FROM THE LONG-TERM EXTENSION THE PHASE III PIVOTAL TRIAL
    Ruperto, N.
    Brunner, H. I.
    Quartier, P.
    Constantin, T.
    Alexeeva, E.
    Kone-Paut, I.
    Marzan, K.
    Wulffraat, N.
    Schneider, R.
    Padeh, S.
    Chasnyk, V.
    Wouters, C.
    Kuemmerle-Deschner, J. B.
    Kallinich, T.
    Lauwerys, B.
    Haddad, E.
    Nasonov, E.
    Trachana, M.
    Vougiouka, O.
    Leon, K.
    Speziale, A.
    Lheritier, K.
    Martini, A.
    Lovell, D.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 401 - 402
  • [10] Efficacy and safety of canakinumab in systemic juvenile idiopathic arthritis, the first Chinese experience
    Lingzhi Qiu
    Le Ma
    Yifan Xie
    Jing Jin
    Yuting Pan
    Shumin Li
    Zhidan Fan
    Haiguo Yu
    [J]. Pediatric Rheumatology, 22
12345